The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Losartan Potassium (NDC 65841-730). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 65841-729-01
Losartan Potassium Tablets USP, 25 mg
Rx Only
100 Tablets
Zydus
25 mg (699213a2 8233 4c3b 826e 6980ccc018b6 01)
NDC 65841-730-01
Losartan Potassium Tablets USP, 50 mg
Rx Only
100 Tablets
Zydus
50 mg (699213a2 8233 4c3b 826e 6980ccc018b6 02)
NDC 65841-731-01
Losartan Potassium Tablets USP, 100 mg
Rx Only
100 Tablets
Zydus
100 mg (699213a2 8233 4c3b 826e 6980ccc018b6 03)
* Please review the disclaimer below.
